In 2024, PF614-MPAR received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA), and had its development bolstered by a $14 million multi-year award from the National ...
In today’s column, I identify and explore a hot trend in the AI field that is variously referred to as Physical AI sometimes ... analysis of an innovative AI breakthrough is part of my ongoing ...
"To identify ideal therapy targets, we developed a novel in vivo screening method that shows which genes are essential to tumor survival," says Taylor, Adjunct Scientist at SickKids and ...
Penn Medicine is advancing cancer treatment with its work in CAR T-cell therapy, an innovative immunotherapy that is reshaping the fight against blood cancers and rare genetic diseases. Penn Medicine ...
Additionally, we will also explore the potential of IBI343 in combination therapy for pancreatic cancer and other solid tumors, including gastric cancer." NMPA Breakthrough Therapy Designation is ...
In 2024, PF614-MPAR received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA), and had its development bolstered by a $14 million multi-year award from the ...
A powerful new telescope will come online this year in a remote region of Chile and begin a decade-long survey of the southern sky. Inside is the largest digital camera ever made for astronomy ...
After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes. California Institute for Regenerative Medicine, Neurona Therapeutics, Vertex ...
Jan. 08, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback